FDA says it is already simplifying access to its IT system, revising SOPs, updating its organizational charts and putting out more guidance documents as recommended in an internal assessment of its inter-center consultation process for combination products released by the agency Oct. 14.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?